Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Global Markets for Emerging Insulin Drug and Delivery Technologies - Focus on Insulin Pumps

Enquire | Email | Print

Single User - $5,370       2 to 5 Users - $6,850       6 to 10 Users - $8,460       11to 20 Users - $10,050       21+ Users - $12,450
Published Date: Aug, 2013
Format: PDF
No of Pages: 128
 
 
Select pricing :
Change Currency: EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

REPORT HIGHLIGHTS

This report provides:

-An overview of global insulin drugs and delivery in pharmaceutical and biotechnology markets with classification and usage in diabetes types, with a focus on insulin pumps.
-Analyses of global market trends, with data from 2011 and 2012, estimates for 2013 and 2018 and projections of compound annual growth rates (CAGRs) through 2018.
-Evaluation of emerging technologies in the insulin drug and delivery field that have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods.
-Patent identifications for insulin as a drug, along with its delivery methods.

INTRODUCTION

STUDY OBJECTIVES


BCC Research’s objective in carrying out this study is to provide an overview of the current and future characteristics of the global market for emerging insulin drugs and delivery technologies. The fundamental objective is to present a comprehensive analysis and identify the future direction of insulin drugs and delivery devices as important tools in treating diabetes with well-tolerated delivery devices.

This report explores present and future strategies within the insulin drug and delivery market, which includes syringes, pumps, pens and many newer methods. The market’s improvisation, setbacks and needs are also discussed. The classifications, comparisons and usage of different insulin types and devices are presented as well.

A detailed analysis of insulin drugs and delivery industry structure has been conducted. Revenues are broken down by type, as well as by region. Sales figures are estimated for the five-year period from 2013 through 2018.

Applications for insulin drugs and delivery are also discussed in a separate section, with emphasis on their usage in treating different types of diabetes. The report also covers significant patents and their allotments in each category.

REASONS FOR DOING THIS STUDY

The emerging technologies in the insulin drug and delivery field have potential in the diabetes market, with improved glucose control, along with improved and well-accepted newer delivery methods. Modern industries and research institutes have begun to explore newer method for diabetes control in adults and juveniles. , leading to a steady market for these technologies.

Research and development (R&D) spending, increasing competition, patent expiries and emerging technologies are guiding this to a new direction. The new advancements, new product launches, and increased awareness and early detection of the disease have influenced the market to grow in the foreseeable future. This study looks at many of the systems affected by these factors.

Companies’ acquisition strategies and collaborations are covered in this report. This study also discusses the strength and weaknesses of each technology type in light of the new technologies, growing competition and changing customer needs.

CONTRIBUTIONS OF THE STUDY AND FOR WHOM

This study contributes to the areas of market growth for insulin drug and delivery manufacturers and users. It will be of interest to pharmaceutical biotechnical companies, research institutes, hospitals and physicians.

SCOPE OF THE STUDY

The scope of this study encompasses insulin drugs and delivery in pharmaceutical and biotechnology markets with its classification and its usage in diabetes types. BCC analyzes each market and its applications, as well as its regulatory environment, technology and market share. The markets, such as type 1 diabetes, type 2 diabetes and gestational diabetes, are analyzed for the years 2011 and 2012. The markets are projected through the end of 2013 and for a five-year period until 2018.

The market is also segmented by insulin syringes and vials, insulin pens and insulin pumps. Technological issues include the latest trends and developments. The study also includes the patent identifications for insulin as a drug, along with its deliveries.

The emerging markets for insulin drug and delivery include India, China, Japan, Korea, Taiwan, Canada, Africa, Australia and New Zealand.

METHODOLOGY

Both primary and secondary research methodologies were used in the preparation of this study. BCC Research conducted a comprehensive literature search, which included technical newsletters and journals, as well as many other sources. Data were collected through interviews and correspondence with manufacturers of enzyme inhibitors technical experts. Projections were based on estimates such as the current number of end users, potential end users, mergers and acquisitions, and market trends.

INFORMATION SOURCES


Many companies were surveyed to obtain data for this study. including manufacturers of insulin drugs and delivery technologies and their users in hospitals and medical centers. Data were gathered from various industry sources. BCC Research spoke with officials within the industry and also consulted newsletters; company literature; product literature; and a host of technical articles, journals, indexes and abstracts. Exhaustive investigations of databases by key terminology were completed. In addition, data were compiled from current financial, trade and government sources.

Chapter- 1: INTRODUCTION - Complimentary 3 $0
STUDY OBJECTIVES
REASONS FOR DOING THIS STUDY
CONTRIBUTIONS OF THE STUDY AND FOR WHOM
SCOPE OF THE STUDY
METHODOLOGY
INFORMATION SOURCES
ABOUT THE AUTHOR
RELATED BCC RESEARCH REPORTS
BCC ONLINE SERVICES
DISCLAIMER

Chapter- 2: SUMMARY 3 $250
Table Summary : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, THROUGH 2018
Figure Summary : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, 2011-2018

Chapter- 3: OVERVIEW 18 $928
DIABETES OVERVIEW
DIABETES CLASSIFICATION
EPIDEMIOLOGY
TYPE 1 DIABETES MELLITUS MANAGEMENT
INSULIN

Chapter- 4: REGULATORY ASPECTS 11 $567
APPROVALS FOR INSULIN DRUGS
APPROVALS GRANTED FOR INSULIN DEVICES
PREMARKET NOTIFICATION OR 510(K) CLEARANCE
SAFETY ALERTS AND RECALLS

Chapter- 5: NEW DEVELOPMENTS 14 $722
NEW TECHNOLOGIES FOR INSULIN DELIVERY
PRODUCT DEVELOPMENT
MERGERS AND ACQUISITIONS
LICENSING, PARTNERSHIPS, AND AGREEMENTS
PIPELINE PRODUCTS

Chapter- 6: GLOBAL MARKETS 23 $1186
MARKET BY TYPE
MARKET BY REGION
MARKET BY APPLICATIONS

Chapter- 7: INSULIN PUMP MARKET ANALYSIS 23 $1186
MARKET BY TYPE
MARKET BY REGION
MARKET BY APPLICATIONS
INDUSTRY STRUCTURE

Chapter- 8: PATENT ANALYSIS 7 $361
PATENTS BY YEAR
PATENTS BY TYPE
PATENTS BY COMPANY
PATENTS BY COUNTRY
PATENTS BY ASSIGNEE

Chapter- 9: CURRENT SITUATION 7 $361
MARKET TRENDS
MODERN INSULIN AND ALTERNATIVE DELIVERY METHODS
OVERALL MARKET DRIVERS FOR INSULIN DELIVERY DEVICE MARKET
FACTORS GOVERNING THE INSULIN DELIVERY DEVICE MARKET
COLLABORATIONS, MERGERS AND AQUISITIONS

Chapter- 10: COMPANY PROFILES 19 $980
ADOCIA
ANIMAS CORPORATION
ANTRIABIO
BECTON, DICKINSON AND COMPANY
BIOCON LIMITED
BIODEL INC.
DEBIOTECH
ELI LILLY
ETERNITY HEALTHCARE
F. HOFFMANN-LA ROCHE LTD. (DISETRONIC MEDICAL SYSTEMS AG)
GENEREX BIOTECHNOLOGY CORPORATION
HALOZYME THERAPEUTICS INC.
INSULINE MEDICAL
INSULUTION ABM
LIFESCAN
MANNKIND
MARINA BIOTECH INC.
MEDTRONIC INC.
MICROPORT SCIENTIFIC CORPORATION
MIDASOL THERAPEUTICS (JOINT VENTURE OF MIDATECH LTD. AND MONOSOL RX)
NOVO NORDISK
ORAMED PHARMACEUTICALS INC.
PHOSPHAGENICS LIMITED
SANOFI
SENSILE MEDICAL AG
THERMALIN DIABETES INC.
XERIS PHARMACEUTICALS
YPSOMED HOLDING AG

List of Tables

Summary Table : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, THROUGH 2018
Table 1 : DISTINGUISHING FEATURES OF TYPE 1 AND TYPE 2 DIABETES
Table 2 : ESTIMATED DIABETES CASES IN 2030 AND POPULATION CHANGES WITH RESPECT TO 2000
Table 3 : HISTORY OF INSULIN ISOLATION AND DEVELOPMENT
Table 4 : CHARACTERISTIC PROPERTIES OF VARIOUS INSULIN FORMULATIONS
Table 5 : ADVANTAGES AND DISADVANTAGES OF SYRINGES
Table 6 : INSULIN PUMPS CURRENTLY ON THE MARKET
Table 7 : COMPARATIVE DEPICTION OF RISK VERSUS BENEFIT FEATURES FOR VARIOUS INSULIN DELIVERY SYSTEMS
Table 8 : INSULIN PENS CURRENTLY ON THE MARKET
Table 9 : INSULIN ADMINISTRATION ROUTES
Table 10 : INSULIN DRUG APPROVALS, 2009-MARCH 2013
Table 11 : PREMARKET APPROVAL SUPPLEMENTAL APPROVALS FOR INSULIN DEVICES, 2009–MARCH 2013
Table 12 : PREMARKET NOTIFICATION OR 510 (K) CLEARANCES FOR INSULIN DEVICES, 2009–MARCH 2013
Table 13 : SAFETY ALERTS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013
Table 14 : DRUG RECALLS FOR INSULIN DRUGS AND DEVICES, 2009–APRIL 2013
Table 15 : NEW DEVELOPMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES
Table 16 : INSULIN DRUG AND DELIVERY DEVICE COMPANY MERGERS AND ACQUISITIONS
Table 17 : LICENSING, PARTNERSHIPS, AND AGREEMENTS FOR INSULIN DRUGS AND DELIVERY DEVICES
Table 18 : INSULIN DRUG AND DELIVERY DEVICE PIPELINE PRODUCTS
Table 19 : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE, THROUGH 2018
Table 20 : INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY TYPE, 2012
Table 21 : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION, THROUGH 2018
Table 22 : INSULIN DRUG AND DELIVERY DEVICE MARKET SHARE BY REGION, 2012
Table 23 : GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, THROUGH 2018
Table 24 : INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012
Table 25 : GLOBAL INSULIN PEN MARKET BY REGION, THROUGH 2018
Table 26 : INSULIN PEN MARKET SHARES BY REGION, 2012
Table 27 : GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018
Table 28 : INSULIN PUMP MARKET SHARES BY REGION, 2012
Table 29 : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION, THROUGH 2018
Table 30 : INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION, 2012
Table 31 : GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018
Table 32 : INSULIN PUMP MARKET SHARES BY TYPE, 2012
Table 33 : GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018
Table 34 : GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH 2018
Table 35 : GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, THROUGH 2018
Table 36 : GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH 2018
Table 37 : INSULIN PUMP MARKET SHARES BY REGION, 2012
Table 38 : GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018
Table 39 : INSULIN PUMP MARKET SHARES BY APPLICATION, 2012
Table 40 : LEADING MANUFACTURERS AND SUPPLIERS OF INSULIN PUMPS
Table 41 : INSULIN PUMP MANUFACTURER MARKET SHARES, 2012
Table 42 : U.S. PATENTS, JANUARY 2009–MARCH 2013
Table 43 : U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013
Table 44 : U.S. PATENTS BY COMPANY, JANUARY 2009-MARCH 2013
Table 45 : U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013
Table 46 : U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013

List of Figures

Summary Figure : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET, 2011-2018
Figure 1 : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY TYPE, 2011-2018
Figure 2 : INSULIN DRUG AND DEVICE MARKET SHARES BY TYPE, 2012
Figure 3 : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY REGION, 2011-2018
Figure 4 : INSULIN DRUG AND DEVICE MARKET SHARE BY REGION, 2012
Figure 5 : GLOBAL INSULIN SYRINGE AND VIAL MARKET BY REGION, 2011-2018
Figure 6 : INSULIN SYRINGE AND VIAL MARKET SHARES BY REGION, 2012
Figure 7 : GLOBAL INSULIN PEN MARKET BY REGION, 2011-2018
Figure 8 : INSULIN PEN MARKET SHARES BY REGION, 2012
Figure 9 : GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018
Figure 10 : INSULIN PUMP MARKET SHARES BY REGION, 2012
Figure 11 : GLOBAL INSULIN DRUG AND DELIVERY DEVICE MARKET BY APPLICATION, 2011-2018
Figure 12 : INSULIN DRUG AND DELIVERY DEVICE MARKET SHARES BY APPLICATION, 2012
Figure 13 : GLOBAL INSULIN PUMP MARKET BY TYPE, THROUGH 2018
Figure 14 : INSULIN PUMP MARKET SHARES BY TYPE, 2012
Figure 15 : GLOBAL INSULIN PUMP MARKET BY REGION, THROUGH 2018
Figure 16 : GLOBAL INSULIN PUMPS WITH TUBING MARKET BY REGION, THROUGH 2018
Figure 17 : GLOBAL TUBELESS INSULIN PUMP MARKET BY REGION, 2011-2018
Figure 18 : GLOBAL IMPLANTABLE INSULIN PUMP MARKET BY REGION, THROUGH 2018
Figure 19 : INSULIN PUMP MARKET SHARES BY REGION, 2012
Figure 20 : GLOBAL INSULIN PUMP MARKET BY APPLICATION, THROUGH 2018
Figure 21 : INSULIN PUMP MARKET SHARES BY APPLICATION, 2012
Figure 22 : INSULIN PUMP MANUFACTURER MARKET SHARES, 2012
Figure 23 : U.S. PATENTS, JANUARY 2009-MARCH 2013
Figure 24 : U.S. INSULIN PATENTS BY TYPE, JANUARY 2009-MARCH 2013
Figure 25 : U.S. PATENTS BY COUNTRY, JANUARY 2009-MARCH 2013
Figure 26 : U.S. PATENTS BY ASSIGNEE, JANUARY 2009-MARCH 2013

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 422877, price: INR 325510, BCC Research

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online